Literature DB >> 25304048

How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia.

Danielle Horyniak1, Mark Stoové2, Louisa Degenhardt3, Campbell Aitken2, Thomas Kerr4, Paul Dietze2.   

Abstract

BACKGROUND: Changes in drug market characteristics have been shown to affect drug use patterns but few studies have examined their impacts on injecting initiation experiences and subsequent patterns of injecting drug use (IDU).
METHODS: We collected data on self-reported injecting initiation experiences and past-month patterns of IDU from 688 regular heroin and methamphetamine injectors in Melbourne, Australia, who initiated injecting across three different drug market periods (prior to the Australian heroin shortage ('high heroin')/immediately following the shortage ('low heroin')/'contemporary' markets (fluctuating heroin and methamphetamine availability)). We used univariable and multivariable logistic regression to examine the relationship between period of injecting initiation and first drug injected, and multinomial logistic regression for the relationship between period of injecting initiation and current injecting patterns.
RESULTS: 425 participants (62%) reported initiating injecting in the high heroin period, 146 (21%) in the low heroin period, and 117 (17%) in the contemporary period. Participants who initiated injecting during the low heroin period were twice as likely to initiate injecting using a drug other than heroin (AOR: 1.94, 95% CI: 1.27-2.95). The most common patterns of drug use among study participants in the month preceding interview were polydrug use (44%) and primary heroin use (41%). Injecting initiation period was either non-significantly or weakly associated with current drug use pattern, which was more strongly associated with other socio-demographic and drug use characteristics, particularly self-reported drug of choice.
CONCLUSION: The drug market period in which injecting initiation occurred influenced the first drug injected and influenced some aspects of subsequent drug use. In the context of highly dynamic drug markets in which polydrug use is common there is a need for broad harm reduction and drug treatment services which are flexible and responsive to changing patterns of drug use.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Australia; Drug markets; Heroin; Initiation; Injecting drug use; Methamphetamine

Mesh:

Substances:

Year:  2014        PMID: 25304048     DOI: 10.1016/j.drugpo.2014.09.002

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  10 in total

Review 1.  The experience of initiating injection drug use and its social context: a qualitative systematic review and thematic synthesis.

Authors:  Andy Guise; Danielle Horyniak; Jason Melo; Ryan McNeil; Dan Werb
Journal:  Addiction       Date:  2017-09-29       Impact factor: 6.526

Review 2.  Injection Drug Use Trajectories among Migrant Populations: A Narrative Review.

Authors:  Jason S Melo; Maria Luisa Mittal; Danielle Horyniak; Steffanie A Strathdee; Dan Werb
Journal:  Subst Use Misuse       Date:  2018-01-24       Impact factor: 2.164

3.  Longitudinal migration patterns from an open illicit drug scene among people who use illicit drugs in Vancouver, Canada.

Authors:  Lianping Ti; Huiru Dong; Andrew Day; Rachael McKendry; Kora DeBeck; Brittany Bingham; M-J Milloy; Rolando Barrios; Kanna Hayashi
Journal:  J Subst Abuse Treat       Date:  2019-10-18

4.  Transitioning from pharmaceutical opioids: A discrete-time survival analysis of heroin initiation in suburban/exurban communities.

Authors:  T L Gaines; K D Wagner; M L Mittal; J M Bowles; E Copulsky; M Faul; R W Harding; P J Davidson
Journal:  Drug Alcohol Depend       Date:  2020-05-28       Impact factor: 4.492

5.  Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors.

Authors:  Andrea M Lopez; Zena Dhatt; Mary Howe; Marwa Al-Nassir; Amy Billing; Eleanor Artigiani; Eric D Wish
Journal:  Int J Drug Policy       Date:  2021-01-19

Review 6.  A rapid review of the impacts of "Big Events" on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19.

Authors:  Camille Zolopa; Stine Hoj; Julie Bruneau; Julie-Soleil Meeson; Nanor Minoyan; Marie-France Raynault; Iuliia Makarenko; Sarah Larney
Journal:  Int J Drug Policy       Date:  2021-01-20

Review 7.  A Narrative Review of the Recent 'Ice' Epidemic: An Australian Perspective.

Authors:  Konrad Pisarski
Journal:  Subst Abuse       Date:  2021-04-21

8.  Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis.

Authors:  Daniel O'Keefe; Nick Scott; Campbell Aitken; Paul Dietze
Journal:  BMC Health Serv Res       Date:  2016-08-19       Impact factor: 2.655

9.  Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012.

Authors:  Maryam Alavi; Jason Grebely; Behzad Hajarizadeh; Janaki Amin; Sarah Larney; Matthew G Law; Jacob George; Louisa Degenhardt; Gregory J Dore
Journal:  BMC Infect Dis       Date:  2018-05-09       Impact factor: 3.090

10.  Association between recreational drug use and sexual practices among people who inject drugs in Southwest China: a cross-sectional study.

Authors:  Lei Zhang; Feng Cheng; Shu Su; Shunxiang Li; Shifu Li; Jun Jing; Christopher Kincaid Fairley; Liang Chen; Jinxian Zhao; Limin Mao
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.